In mice with transgenically overexpressed galectin 3, fasting glycemia was similar to the WT control group on HFD but with significantly higher compensatory hyperinsulinemia as a consequence of increased activity and insulin production by β cells. The gene discussed is INS; the disease is hyperinsulinism.